The epidemiology of lymphangioleiomyomatosis in Japan: A nationwide cross-sectional study of presenting features and prognostic factors

被引:77
作者
Hayashida, Mie
Seyama, Kuniaki
Inoue, Yoshikazu
Fujimoto, Keisaku
Kubo, Keishi
机构
[1] Shinshu Univ, Sch Med, Dept Internal Med, Matsumoto, Nagano 3908621, Japan
[2] Juntendo Univ, Sch Med, Dept Resp Med, Tokyo, Japan
[3] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Diffuse Lung Dis & Resp Failure, Osaka, Japan
关键词
lung function; lymphangioleiomyomatosis; phenotype; presenting features; prognosis;
D O I
10.1111/j.1440-1843.2007.01101.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objectives: To evaluate the characteristics and prognostic factors of Japanese patients with lymphangioleiomyomatosis (LAM). Methods: A nationwide survey to identify patients with LAM was conducted by questionnaire. Survival probability was estimated using the Kaplan-Meier method, and the prognostic factors were analysed by Cox regression. Results: Data were collected on 173 patients with pulmonary LAM. The major presenting features were pneumothorax (43%) and exertional dyspnoea (37%). The survival probabilities for patients presenting with exertional dyspnoea (Group A) were 85%, 60% and 47% after 5, 10 and 15 years, respectively, and for patients presenting with pneumothorax (Group B) were 95%, 89% and 89%, respectively. Although the age at symptom onset was higher among patients in Group A than in Group B, Cox regression revealed that the presenting feature was a prognostic factor independent of age at symptom onset (Group A/B hazard ratio = 5.732, P < 0.01). In the subgroup of patients whose initial FEV1 was > 1000 mL, or FEV1/FVC > 40%, or %DLCO > 40%, the rate of deterioration in these tests was greater in Group A than in Group B (P < 0.01 for FEV1, P < 0.05 for FEV1/FVC and %DLCO). Conclusions: There are two possible subgroups of LAM patients. One subgroup that presented with pneumothorax, had onset of symptoms at a younger age and a more favourable prognosis; the other presented with exertional dyspnoea, had onset of symptoms at an older age and a poorer prognosis.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 26 条
[1]   Lymphangioleiomyomatosis: Correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis [J].
Avila, NA ;
Kelly, JA ;
Dwyer, AJ ;
Johnson, DL ;
Jones, EC ;
Moss, J .
RADIOLOGY, 2002, 223 (01) :189-197
[2]   Lymphangioleiomyomatosis: Abdominopelvic CT and US findings [J].
Avila, NA ;
Kelly, JA ;
Chu, SC ;
Dwyer, AJ ;
Moss, J .
RADIOLOGY, 2000, 216 (01) :147-153
[3]   PULMONARY MECHANICS IN LYMPHANGIOLEIOMYOMATOSIS [J].
BURGER, CD ;
HYATT, RE ;
STAATS, BA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :1030-1033
[4]   Emerging clinical picture of lymphangioleiomyomatosis [J].
Cohen, MM ;
Pollock-BarZiv, S ;
Johnson, SR .
THORAX, 2005, 60 (10) :875-879
[5]  
CORRIN B, 1975, AM J PATHOL, V79, P348
[6]   Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis [J].
Crausman, RS ;
Lynch, DA ;
Mortenson, RL ;
King, TE ;
Irvin, CG ;
Hale, VAE ;
Newell, JD .
CHEST, 1996, 109 (01) :131-137
[7]   Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis [J].
Inoue, Y ;
King, TE ;
Barker, E ;
Daniloff, E ;
Newman, LS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) :765-773
[8]   Clinical experience of lymphangioleiomyomatosis in the UK [J].
Johnson, SR ;
Tattersfield, AE .
THORAX, 2000, 55 (12) :1052-1057
[9]   Decline in lung function in lymphangioleiomyomatosis - Relation to menopause and progesterone treatment [J].
Johnson, SR ;
Tattersfield, AE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :628-633
[10]   Survival and disease progression in UK patients with lymphangioleiomyomatosis [J].
Johnson, SR ;
Whale, CI ;
Hubbard, RB ;
Lewis, SA ;
Tattersfield, AE .
THORAX, 2004, 59 (09) :800-803